| Your Current Location : Fund Card : Fund Summary |
 |
|
|
| |
| Nippon India Pharma Fund (G) Direct |
| [Equity: Sectoral] |
|
|
| |
| Fund Details |
| Fund Type |
Growth |
Launch Date |
14 Jan 2013 |
| Corpus(Cr.) |
5545.0 |
Scheme NAV |
384.52 |
| Equity(%) |
96.75 |
52 Week High |
388.514 |
| Debt(%) |
3.25 |
52 Week Low |
289.43 |
| Others(%) |
0.0 |
Exit Load |
1% for redemption Within 30 days |
| Minimum Investment |
- |
Availability |
Open |
| Entry Load |
- |
Expense Ratio(%) |
1.02 |
| Scheme Benchmark |
S&P BSE Healthcare TRI |
Broader Benchmark |
NSE - Nifty 50 TRI |
|
| |
| Scheme Objective |
| Investment Strategy The scheme seeks to generate consistent returns by investing in equity / equity related or fixed income securities of pharma and other associated companies. |
| |
|
|
| |
|
|
| |
|
 |
| |
|
|
|
